CARL.US Carlsmed, Inc.

Healthcare Health Care Equipment & Supplies USA Stocks
17.12 USD
Close of Nov 14, 2026
8.50 19.15
Market cap
USD 469M
P/E
-
P/B
6.30x
ROE
-55.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CARL.US undervalued?

Graham number

The Graham number of Carlsmed, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Carlsmed, Inc. fundamental analysis

No fundamental analysis for Carlsmed, Inc. yet.

Carlsmed, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Carlsmed, Inc.

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The …

Full company profile